
tirzepatide
Tirzepatide acts on two appetite hormones, GIP and GLP-1, in one shot a week. One KwikPen holds a month of doses. FDA approved for weight loss.
From
$299/mo
without insurance
20.9%
Average loss
Plus Curie's $30 monthly service fee.
Get my Zepbound® KwikPenYour provider confirms the right medication and dose during your checkup.
20.9%
On average, people on the 15 mg dose of Zepbound® lost 20.9% of their body weight in 72 weeks.
SURMOUNT-1 Trial, New England Journal of Medicine, 2022
Slide to your current weight.
Select your current weight
245
Your new weight
194
The average on the 15 mg dose in SURMOUNT-1. Your results may differ.
Once a week.
The same day each week, at any time of day, with or without food.
Inject under the skin, and move to a new spot each week.
Attach a new needle for every dose. One pen lasts the month.
Your dose rises as your body adjusts.
Compare the lineup.
In studies in rodents, Zepbound and medicines like it caused thyroid tumors, including thyroid cancer. It is not known if Zepbound causes these tumors in people. Do not use Zepbound if you or a family member has had medullary thyroid carcinoma (MTC), or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your provider about a lump or swelling in your neck, trouble swallowing, hoarseness or shortness of breath. Serious side effects can include inflammation of the pancreas, severe stomach problems, gallbladder problems, low blood sugar with other diabetes medicines, kidney problems from dehydration, serious allergic reactions, vision changes in people with type 2 diabetes, depression or thoughts of suicide, and food or liquid getting into the lungs during surgery or sedation. Zepbound can make birth control pills work less well for 4 weeks after you start and after each dose increase. Tell your provider if you are pregnant, plan to become pregnant, or are breastfeeding.